Dr. Poland is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
200 1st St Sw
Rochester, MN 55905Phone+1 507-284-2511
Education & Training
Abbott-Northwestern HospitalChief Residency, Internal Medicine, 1984 - 1985- Abbott-Northwestern HospitalResidency, Internal Medicine, 1981 - 1985
- Abbott-Northwestern HospitalResidency, Internal Medicine, 1980 - 1985
University of MinnesotaResidency, Physical Medicine and Rehabilitation, 1980 - 1980
Southern Illinois University School of MedicineClass of 1980
Certifications & Licensure
MN State Medical License 1981 - 2025
TN State Medical License 1985 - 1988
American Board of Internal Medicine Internal Medicine
Clinical Trials
- Comparison of the Immunogenicity, Safety and Reactogenicity of FluBlok, To a Licensed Vaccine In Elderly Adults Start of enrollment: 2006 Oct 01
Publications & Presentations
PubMed
- Quantum vaccinology: A new science and epistemological abstraction framework for developing new vaccines and understanding the generation of the immune response.Gregory A Poland, José de la Fuente
Vaccine. 2025-02-06 - Influenza vaccination for children in Europe: The health of every child matters.Helena C Maltezou, Gregory A Poland, Raul Ortiz de Lejarazu
Vaccine. 2025-02-06 - Transcriptomic Signatures Predict Rubella Virus-Induced Cytokine and Chemokine Responses in Female MMR Recipients.Tamar Ratishvili, Iana H Haralambieva, Huy Q Quach, Ilya M Swanson, Krista M Goergen
European Journal of Immunology. 2025-02-01
Journal Articles
- Review Strategies to Maximize Influenza Vaccine Impact in Older AdultsGregory Poland, MD, ScienceDirect
- Editorial Vaccinology in the 21st Century–the 10th Annual Vaccine CongressGregory Poland, MD, ScienceDirect
Press Mentions
Virtually Ouch-Free: Promising Early Data on a Measles Vaccine Delivered via StickerMay 26th, 2023- If Bird Flu Starts to Spread Among People, Existing Vaccines May Be Inadequate, Experts SayMay 21st, 2023
- The Federal COVID-19 Emergency Order Expires Thursday. What Will Change in Kansas City?May 11th, 2023
- Join now to see all
Grant Support
- Immunogenetic Mechanisms Of Vaccine ResponseNational Institute Of Allergy And Infectious Diseases2011–2012
- The Immunogenetics Of Measles ImmunityNational Institute Of Allergy And Infectious Diseases2004–2012
- Bioinformatics Approach To Influenza A/H1N1 Vaccine Immune ProfilingNational Institute Of Allergy And Infectious Diseases2010–2011
- Immunogenetic Mechanisms Of Vaccine ResponseNational Institute Of Allergy And Infectious Diseases2004–2010
- Population Genetics Analysis PROGRAM: Immunity To Vaccines/InfectionsNational Institute Of Allergy And Infectious Diseases2007
- Trial Of Rpa102 Vaccine In Healthy Adult VolunteersNational Center For Research Resources2005
- Anthrax Vaccine Absorbed (Ava): A Human Reactogenicity And Immunogenicity TrialNational Center For Research Resources2005
- Anthrax Vaccine Absorbed--Human Reactogenicity TrialNational Center For Research Resources2004
- The Immunogenetics Of Measles ImmunityNational Institute Of Allergy And Infectious Diseases2002–2003
- Immunogenetic Mechanisms Of Vaccine ResponseNational Institute Of Allergy And Infectious Diseases2001–2003
- Nature Of Measles Immunity In Two PopulationsNational Institute Of Allergy And Infectious Diseases1997–2001
- Data Of HLA System To Develop And Improve VaccinesNational Center For Research Resources1996–1999
- HLA And Vaccines (BAA)National Institute Of Allergy And Infectious Diseases1994–1998
- Measles Immunity In Two PopulationsNational Institute Of Allergy And Infectious Diseases1993–1996
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
